Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic...

por Bouchahda, Mohamed, Ulusakarya, Ayhan, Thirot-Bidault, Anne, Attari, Amal, Bossevot, Rachel, Tuligenga, Richard, Hammel, Pascal, Adam, René, Levi, Francis
Publicado 2023

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study

por Zaanan, Aziz, Trouilloud, Isabelle, Markoutsaki, Theofano, Gauthier, Mélanie, Dupont-Gossart, Anne-Claire, Lecomte, Thierry, Aparicio, Thomas, Artru, Pascal, Thirot-Bidault, Anne, Joubert, Fanny, Fanica, Daniella, Taieb, Julien
Publicado 2014

Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study

por Williet, Nicolas, Saint, Angélique, Pointet, Anne-Laure, Tougeron, David, Pernot, Simon, Pozet, Astrid, Bechade, Dominique, Trouilloud, Isabelle, Lourenco, Nelson, Hautefeuille, Vincent, Locher, Christophe, Desrame, Jérome, Artru, Pascal, Thirot Bidault, Anne, Le Roy, Bertrand, Pezet, Denis, Phelip, Jean-Marc, Taieb, Julien
Publicado 2019

BRAF Mutation Status in Circulating Tumor DNA from Patients with Metastatic Colorectal Cancer: Extended Mutation Analysis from the AGEO RASANC Study

por Mas, Leo, Bachet, Jean-Baptiste, Taly, Valerie, Bouché, Olivier, Taieb, Julien, Cohen, Romain, Meurisse, Aurelia, Normand, Corinne, Gornet, Jean-Marc, Artru, Pascal, Louafi, Samy, Thirot-Bidault, Anne, Baumgaertner, Isabelle, Coriat, Romain, Tougeron, David, Lecomte, Thierry, Mary, Florence, Aparicio, Thomas, Marthey, Lysiane, Blons, Helene, Vernerey, Dewi, Laurent-Puig, Pierre
Publicado 2019